Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 14
2003 23
2004 28
2005 9
2006 14
2007 16
2008 16
2009 13
2010 17
2011 25
2012 9
2013 21
2014 17
2015 15
2016 16
2017 21
2018 10
2019 14
2020 9
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

283 results
Results by year
Filters applied: . Clear all
Page 1
Hepatitis B virus infection.
Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL. Yuen MF, et al. Among authors: lai cl. Nat Rev Dis Primers. 2018 Jun 7;4:18035. doi: 10.1038/nrdp.2018.35. Nat Rev Dis Primers. 2018. PMID: 29877316 Review.
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, Abergel A, Mangia A, Lai CL, Chan HL, Mazzotta F, Moreno C, Yoshida E, Shafran SD, Towner WJ, Tran TT, McNally J, Osinusi A, Svarovskaia E, Zhu Y, Brainard DM, McHutchison JG, Agarwal K, Zeuzem S; ASTRAL-1 Investigators. Feld JJ, et al. Among authors: lai cl. N Engl J Med. 2015 Dec 31;373(27):2599-607. doi: 10.1056/NEJMoa1512610. Epub 2015 Nov 16. N Engl J Med. 2015. PMID: 26571066 Free article. Clinical Trial.
RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection.
Yuen MF, Schiefke I, Yoon JH, Ahn SH, Heo J, Kim JH, Lik Yuen Chan H, Yoon KT, Klinker H, Manns M, Petersen J, Schluep T, Hamilton J, Given BD, Ferrari C, Lai CL, Locarnini SA, Gish RG. Yuen MF, et al. Among authors: lai cl. Hepatology. 2020 Jul;72(1):19-31. doi: 10.1002/hep.31008. Epub 2020 Apr 23. Hepatology. 2020. PMID: 31654573 Free PMC article. Clinical Trial.
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.
Wooddell CI, Yuen MF, Chan HL, Gish RG, Locarnini SA, Chavez D, Ferrari C, Given BD, Hamilton J, Kanner SB, Lai CL, Lau JYN, Schluep T, Xu Z, Lanford RE, Lewis DL. Wooddell CI, et al. Among authors: lai cl. Sci Transl Med. 2017 Sep 27;9(409):eaan0241. doi: 10.1126/scitranslmed.aan0241. Sci Transl Med. 2017. PMID: 28954926 Free PMC article. Clinical Trial.
Safety evaluation of telbivudine.
But DY, Yuen MF, Fung J, Lai CL. But DY, et al. Among authors: lai cl. Expert Opin Drug Saf. 2010 Sep;9(5):821-9. doi: 10.1517/14740338.2010.507190. Expert Opin Drug Saf. 2010. PMID: 20662545 Review.
Viral hepatitis C.
Poynard T, Yuen MF, Ratziu V, Lai CL. Poynard T, et al. Among authors: lai cl. Lancet. 2003 Dec 20;362(9401):2095-100. doi: 10.1016/s0140-6736(03)15109-4. Lancet. 2003. PMID: 14697814 Review.
Viral hepatitis B.
Lai CL, Ratziu V, Yuen MF, Poynard T. Lai CL, et al. Lancet. 2003 Dec 20;362(9401):2089-94. doi: 10.1016/S0140-6736(03)15108-2. Lancet. 2003. PMID: 14697813 Review.
Hepatitis B core protein as a therapeutic target.
Mak LY, Wong DK, Seto WK, Lai CL, Yuen MF. Mak LY, et al. Among authors: lai cl. Expert Opin Ther Targets. 2017 Dec;21(12):1153-1159. doi: 10.1080/14728222.2017.1397134. Epub 2017 Nov 1. Expert Opin Ther Targets. 2017. PMID: 29065733 Free article. Review.
283 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page